$PGEN· SEC filing ·

PGEN Reports $3.4M Q4 Revenue, FDA Approval of PAPZIMEOS, $100.4M Cash, J-Code Assigned

Precigen, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $4.12

Post-detection moves

1h
1d
3d
7d
30d

Get alerts like this in real time

Push notifications the moment a signal fires. No spam, no crypto, no fluff.

Download for iOS